Evotec Leverages Infectious Diseases Space With Sanofi R&D Deal

 
• By Sten Stovall

Evotec's CEO tells Scrip its pact with Sanofi to develop an infectious disease pipeline could offer a commercially viable approach to battling the global AMR crisis.

Infectious diseases
Pact aims to accelerate drug discovery to combat Infectious diseases • Source: Shutterstock

More from Business

More from Scrip